Matsumoto, Japan

Den-ichi Momose

This inventor holds 5 USPTO granted patents. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 1989-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Den-ichi Momose. Retrieved from https://idiyas.com/inventor/den-ichi-momose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1989-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Den-ichi Momose: Innovator in Therapeutic Compounds

Introduction

Den-ichi Momose is a notable inventor based in Matsumoto, Japan. He has made significant contributions to the field of therapeutic compounds, holding a total of 5 patents. His work focuses on developing innovative solutions for treating allergic diseases.

Latest Patents

Among his latest patents are the 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds and the 5H-pyrazolo[4,3-A] quinolizin-5-one compounds. These inventions provide novel compounds that exhibit selective inhibitory activity against IgE-antibody formation. They have potential utility in treating allergic diseases associated with IgE formation in mammals, such as allergic bronchial asthma, allergic rhinitis, atopic dermatitis, and hypersensitivity.

Career Highlights

Den-ichi Momose is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His research and inventions have contributed to advancements in therapeutic treatments.

Collaborations

He has collaborated with notable coworkers, including Yoshikazu Kurashina and Hiroshi Miyata, who have supported his research endeavors.

Conclusion

Den-ichi Momose's work in developing therapeutic compounds showcases his commitment to addressing allergic diseases through innovative solutions. His contributions are significant in the pharmaceutical industry and continue to impact the lives of many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…